Dov Elefant insider trades

Open-market stock purchases and sales by Dov Elefant, Chief Financial Officer at Femasys Inc, from SEC Form 4 filings since Sep 21, 2015.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -21%.

Recent trades

DateStockTradeValue
Aug 7, 2026FEMY Femasys IncBought$50K
Aug 7, 2026FEMY Femasys IncBought (not open market)$46.1K
Mar 19, 2026FEMY Femasys IncBought (not open market)$19.8K
Feb 19, 2026FEMY Femasys IncBought (not open market)—
Feb 19, 2026FEMY Femasys IncBought (not open market)—
Nov 7, 2025FEMY Femasys IncBought (not open market)$37.5K

Companies traded

  • FEMY Femasys Inc: 1 buy, last Aug 7, 2026
  • CLRB Cellectar Biosciences, Inc: 3 buys, last Jan 25, 2022
  • AKTX Akari Therapeutics plc: other filings, last Sep 21, 2015

Get free alerts when Dov Elefant files a new trade →